Back to search

Aristotle University Of Thessaloniki (AUTH)

Μελέτη μοριακών και γενετικών δεικτών σε ασθενείς με καρκίνο του στομάχου

Abstract

dc:description

The optimal adjuvant treatment for gastric cancer remains controversial. We compared the efficacy of a docetaxel and platinum adjuvant chemotherapy regimen in patients with high-risk gastric cancer with that of the same chemotherapy plus radiotherapy. The prognostic value of EGFR, ERCC1, HER2, c-MET/HGFR, MAP-Tau, and PTEN expression was also studied in a subset of 67 patients using immunohistochemistry on tissue microarrays (TMA). Patients with histologically proven, radically resected gastric cancer, stage IB-IV were allocated 6 cycles of docetaxel with cisplatin or Carboplatin AUC5 every 3 weeks (arm A) or the same treatment with radiotherapy (arm B) (4500 cGy). A total of 147 patients were randomised. After a median follow-up of 53.7 months no differences in overall and disease-free survival were found between the two arms. The most common grade 3 and 4 toxicities (excluding alopecia) were neutropenia (11% and 17% respectively), febrile neutropenia (9% and 7%) and diarrhea (7% and 4%). Patients with ERCC1 positive tumors had significantly longer median DFS (33.1 vs. 11.8 months, wald p=0.016) and OS (63.2 vs. 18.8 months, wald p=0.046). None of the other markers had statistically significant value related to OS and DFS. Our results indicate that the addition of radiotherapy to platinum/docetaxel adjuvant therapy does not appear to improve prognosis in high-risk, radically resected gastric cancer. ERCC1 expression and correlation with survival in resected gastric cancer awaits validation in larger groups of patients.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Karina, Maria
  • Καρίνα, Μαρία

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/19046

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Karina, Maria; Καρίνα, Μαρία. Μελέτη μοριακών και γενετικών δεικτών σε ασθενείς με καρκίνο του στομάχου. Aristotle University Of Thessaloniki (AUTH), 2009. http://hdl.handle.net/10442/hedi/19046